Yangliu Xia

1.3k total citations
55 papers, 973 citations indexed

About

Yangliu Xia is a scholar working on Pharmacology, Molecular Biology and Pharmacology. According to data from OpenAlex, Yangliu Xia has authored 55 papers receiving a total of 973 indexed citations (citations by other indexed papers that have themselves been cited), including 26 papers in Pharmacology, 25 papers in Molecular Biology and 11 papers in Pharmacology. Recurrent topics in Yangliu Xia's work include Pharmacogenetics and Drug Metabolism (20 papers), Chronic Lymphocytic Leukemia Research (6 papers) and Pharmacological Effects of Natural Compounds (6 papers). Yangliu Xia is often cited by papers focused on Pharmacogenetics and Drug Metabolism (20 papers), Chronic Lymphocytic Leukemia Research (6 papers) and Pharmacological Effects of Natural Compounds (6 papers). Yangliu Xia collaborates with scholars based in China, United States and Finland. Yangliu Xia's co-authors include Frank J. Gonzalez, Ping Wang, Guang‐Bo Ge, Ling Yang, Tingting Yan, Nana Yan, Haiping Hao, Yong Liu, Guangji Wang and Xia Lv and has published in prestigious journals such as SHILAP Revista de lepidopterología, The FASEB Journal and Journal of Medicinal Chemistry.

In The Last Decade

Yangliu Xia

55 papers receiving 958 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Yangliu Xia China 17 385 249 183 150 109 55 973
Zhixia Qiu China 21 448 1.2× 159 0.6× 108 0.6× 185 1.2× 155 1.4× 65 1.1k
Dongxue Sun China 19 544 1.4× 170 0.7× 166 0.9× 143 1.0× 86 0.8× 55 1.3k
Yuqing Zhao China 21 670 1.7× 243 1.0× 92 0.5× 84 0.6× 147 1.3× 92 1.3k
Zhongwen Yuan China 22 660 1.7× 205 0.8× 123 0.7× 132 0.9× 199 1.8× 59 1.5k
Pengcheng Wang United States 19 512 1.3× 246 1.0× 148 0.8× 253 1.7× 36 0.3× 39 1.3k
Zhijun Wang China 22 562 1.5× 190 0.8× 105 0.6× 116 0.8× 142 1.3× 76 1.6k
Achinto Saha United States 20 731 1.9× 203 0.8× 81 0.4× 273 1.8× 84 0.8× 43 1.7k
Dan He China 20 410 1.1× 145 0.6× 76 0.4× 55 0.4× 79 0.7× 70 1.0k
Vinothkumar Rajamanickam China 23 595 1.5× 138 0.6× 83 0.5× 97 0.6× 102 0.9× 34 1.2k
Qianmei Zhou China 18 585 1.5× 133 0.5× 105 0.6× 134 0.9× 183 1.7× 45 1.0k

Countries citing papers authored by Yangliu Xia

Since Specialization
Citations

This map shows the geographic impact of Yangliu Xia's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yangliu Xia with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yangliu Xia more than expected).

Fields of papers citing papers by Yangliu Xia

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yangliu Xia. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yangliu Xia. The network helps show where Yangliu Xia may publish in the future.

Co-authorship network of co-authors of Yangliu Xia

This figure shows the co-authorship network connecting the top 25 collaborators of Yangliu Xia. A scholar is included among the top collaborators of Yangliu Xia based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yangliu Xia. Yangliu Xia is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Sun, Jie, et al.. (2025). Coumarin derivatives as inhibitors against monoamine oxidase: structure-activity relationships and inhibitory mechanisms. SHILAP Revista de lepidopterología. 4(2). 1 indexed citations
2.
Lv, Xin, et al.. (2024). Inhibition of human UDP-glucuronosyltransferase (UGT) enzymes by darolutamide: Prediction of in vivo drug-drug interactions. Chemico-Biological Interactions. 403. 111246–111246. 3 indexed citations
3.
Xia, Yangliu, Yang Zhang, Nana Yan, et al.. (2024). Intestinal stearoyl-coenzyme A desaturase-inhibition improves obesity-associated metabolic disorders. Acta Pharmaceutica Sinica B. 15(2). 892–908. 4 indexed citations
4.
Lv, Xin, Zhe Wang, Zhen Wang, et al.. (2023). Inhibition of human UDP-glucuronosyltransferase enzyme by ripretinib: Implications for drug-drug interactions. Toxicology and Applied Pharmacology. 466. 116490–116490. 8 indexed citations
5.
Lv, Xin, et al.. (2023). Drug-drug interaction potentials of tucatinib inhibition of human UDP-glucuronosyltransferases. Chemico-Biological Interactions. 381. 110574–110574. 7 indexed citations
6.
Wang, Zhe, Xiaoyu Wang, Xin Lv, et al.. (2022). Potential food-drug interaction risk of thymoquinone with warfarin. Chemico-Biological Interactions. 365. 110070–110070. 7 indexed citations
7.
Wang, Xiaoyu, Xin Lv, Xiaoyu Fan, et al.. (2022). In vitro effects of opicapone on activity of human UDP-glucuronosyltransferases isoforms. Toxicology Letters. 367. 3–8. 6 indexed citations
8.
Zhao, Dongfang, Yufan Fan, Fangyuan Wang, et al.. (2021). Discovery and characterization of naturally occurring potent inhibitors of catechol-O-methyltransferase from herbal medicines. RSC Advances. 11(17). 10385–10392. 13 indexed citations
9.
Xia, Yangliu, et al.. (2021). Combined analysis of metagenomic data revealed consistent changes of gut microbiome structure and function in inflammatory bowel disease. Journal of Applied Microbiology. 131(6). 3018–3031. 25 indexed citations
10.
Xia, Yangliu, Ping Wang, Keisuke Hamada, et al.. (2021). Withaferin A in the Treatment of Liver Diseases: Progress and Pharmacokinetic Insights. Drug Metabolism and Disposition. 50(5). 685–693. 19 indexed citations
11.
Xia, Yangliu, Ping Wang, Nana Yan, Frank J. Gonzalez, & Tingting Yan. (2021). Withaferin A alleviates fulminant hepatitis by targeting macrophage and NLRP3. Cell Death and Disease. 12(2). 174–174. 29 indexed citations
12.
Wang, Fangyuan, Ping Wang, Dongfang Zhao, et al.. (2020). Analytical methodologies for sensing catechol-O-methyltransferase activity and their applications. Journal of Pharmaceutical Analysis. 11(1). 15–27. 15 indexed citations
13.
Xia, Yangliu, et al.. (2019). Glucuronidation of d-Luciferin In Vitro: Isoform Selectivity and Kinetics Characterization. European Journal of Drug Metabolism and Pharmacokinetics. 44(4). 549–556. 2 indexed citations
14.
Jiang, Lili, Zhen Wang, Zhongmin Zhang, et al.. (2019). Preparation of an Electrically Conductive Graphene Oxide/Chitosan Scaffold for Cardiac Tissue Engineering. Applied Biochemistry and Biotechnology. 188(4). 952–964. 101 indexed citations
15.
Lv, Xia, Yangliu Xia, Moshe Finel, et al.. (2018). Recent progress and challenges in screening and characterization of UGT1A1 inhibitors. Acta Pharmaceutica Sinica B. 9(2). 258–278. 69 indexed citations
16.
Xia, Yangliu, et al.. (2018). Interspecies comparison in the COMT-mediated methylation of 3-BTD. RSC Advances. 8(29). 16278–16284. 4 indexed citations
17.
Wang, Ping, Yangliu Xia, Li‐Wei Zou, et al.. (2017). An Optimized Two‐Photon Fluorescent Probe for Biological Sensing and Imaging of Catechol‐O‐Methyltransferase. Chemistry - A European Journal. 23(45). 10800–10807. 43 indexed citations
18.
Lv, Xia, Jie Hou, Yangliu Xia, et al.. (2015). Glucuronidation of bavachinin by human tissues and expressed UGT enzymes: Identification of UGT1A1 and UGT1A8 as the major contributing enzymes. Drug Metabolism and Pharmacokinetics. 30(5). 358–365. 17 indexed citations
19.
Sun, Dongxue, Liangliang Zhu, Ling Xiao, et al.. (2014). In vitroglucuronidation of Armillarisin A: UDP-glucuronosyltransferase 1A9 acts as a major contributor and significant species differences. Xenobiotica. 44(11). 988–995. 5 indexed citations
20.
Xia, Yangliu, Sicheng Liang, Liangliang Zhu, et al.. (2013). Identification and Characterization of Human UDP-glucuronosyltransferases Responsible for the Glucuronidation of Fraxetin. Drug Metabolism and Pharmacokinetics. 29(2). 135–140. 30 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Zhixia Qiu Breakdown of academic impact, for papers by Dongxue Sun Breakdown of academic impact, for papers by Yuqing Zhao Breakdown of academic impact, for papers by Zhongwen Yuan Breakdown of academic impact, for papers by Pengcheng Wang Breakdown of academic impact, for papers by Zhijun Wang Breakdown of academic impact, for papers by Achinto Saha Breakdown of academic impact, for papers by Dan He Breakdown of academic impact, for papers by Vinothkumar Rajamanickam Breakdown of academic impact, for papers by Qianmei Zhou
Rankless by CCL
2026